Alpha 2.0
Login Register
» Articles » PMID: 24516304

Report of Chronic Myeloid Leukemia from SEAROC Experience, Jaipur over a Period of 9 Years

Overview
Journal Indian J Med Paediatr Oncol
Publisher Thieme
Specialty Oncology
Date 2014 Feb 12
PMID 24516304
Citations 2
Authors
Anish Maru
Affiliations
Soon will be listed here.
Abstract

SEAROC cancer center presented the data 387 patients from the city of Jaipur. This oncology center caters large number of population from Jaipur as well as from neighboring states. Out of the 387 patients, 334 (86%) patients were in chronic phase. Complete hematological response was seen in 368 (95%) of patients and no response in 5 patients. Among these patients, 33 (8.5%) progressed to blast crisis.

Citing Articles

Chronic Myeloid Leukemia in India.

Ganesan P, Kumar L J Glob Oncol. 2017; 3(1):64-71.

PMID: 28717743 PMC: 5493229. DOI: 10.1200/JGO.2015.002667.

Summary of the published Indian data on chronic myeloid leukemia.

Singhal M, Sengar M, Nair R South Asian J Cancer. 2016; 5(3):162-5.

PMID: 27606306 PMC: 4991141. DOI: 10.4103/2278-330X.187593.

References
1.
Lee S . Chronic myelogenous leukaemia. Br J Haematol. 2001; 111(4):993-1009. DOI: 10.1046/j.1365-2141.2000.02216.x. View
2.
Marin D, Marktel S, Bua M, Armstrong L, Goldman J, Apperley J . The use of imatinib (STI571) in chronic myelod leukemia: some practical considerations. Haematologica. 2002; 87(9):979-88. View
3.
Goldman J . How I treat chronic myeloid leukemia in the imatinib era. Blood. 2007; 110(8):2828-37. DOI: 10.1182/blood-2007-04-038943. View
4.
Pye S, Cortes J, Ault P, Hatfield A, Kantarjian H, Pilot R . The effects of imatinib on pregnancy outcome. Blood. 2008; 111(12):5505-8. PMC: 4916938. DOI: 10.1182/blood-2007-10-114900. View